Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Garheng Kong


  • Large Shareholder, Director at Venus Concept Inc. (VERO), 2019-11-08
  • Large Shareholder at Castle Biosciences Inc (CSTL), 2019-08-01
  • Director at Alimera Sciences Inc (ALIM), 2019-06-20
  • Director at Avedro Inc (AVDR), 2019-06-18
  • Director at Strongbridge Biopharma Plc (SBBP), 2019-05-16
  • Director at Laboratory Corp Of America Holdings (LH), 2019-02-14
  • Director at Histogenics Corp (HSGX), 2018-06-19
  • Director at Melinta Therapeutics Inc. W (MLNT), 2018-06-14
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AVDR $14.00 142,857 Director 1,437,096 2019-02-19 Filing
CEMP $17.43 2,830 Director 2,830 2015-10-26 Filing